A powerful tool for cancer

A cancer diagnosis is stressful and overwhelming. We’re here to help.

Understanding your genes can help guide you and your doctor to the most effective treatments, bringing you one step closer to beating cancer and then staying healthy in the long term.

Genetic testing and cancer

Genetic testing and cancer

Half of all men and one-third of all women in the US will develop cancer during their lifetimes.¹

In many cases, a person’s genetics has made them more susceptible to cancer—and, as a result, they may respond differently to therapies, benefit from more aggressive treatment, or take action to avoid getting cancer again in the future.

Jered Timm

1 in 8 patients

with cancer has a gene mutation passed down through their family

One-third of patients with high-risk mutations could benefit from different, more tailored cancer treatment after genetic testing.²

How testing works

We know you’re getting a lot of tests right now. Our genetic tests can be started from the comfort of your home with a simple saliva sample.
  • step 1

    Step 1

    Request a test online via a telehealth clinician or work with your doctor.
  • icon test box

    Step 2

    Provide a saliva sample from the comfort of your home and ship it to our lab.
  • Icon Genetic Councelor

    Step 3

    Get your results and share them with your doctor. If you'd like, talk to a genetic counselor at no extra cost.
Find the right test

Find the right test

Invitae offers a number of tests focused on specific types of cancer. Each comes with clear next steps, so you and your doctor can make decisions personalized to your genes.

Ready to get started?


1. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2016, National Cancer Institute. Bethesda, MD. Accessed December 7, 2020. https://www.cancer.org/cancer/cancer-basics/lifetime-probability-of-developing-or-dying-from-cancer.html/references, based on November 2018 SEER data submission, posted to the SEER web site, April 2019. Revised January 13, 2020.
2. Samadder NJ, Riegert-Johnson D, Boardman L, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. Published online October 30, 2020. doi:10.1001/jamaoncol.2020.6252